Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Endovia Health SciencesEDVA +3.56%20 EV-to-EBIT is -0.63 as of Aug. 25, 2026. GuruFocus rates EDVA with a GF Score™ of 20/100. The stock has 8 warning signs investors should review. Among 161 Beverages - Alcoholic companies, Endovia Health Sciences ranks worse than 621117.39% on this metric.
Endovia Health Sciences (AMEX:EDVA) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Endovia Health Sciences's Enterprise Value for the quarter that ended in Jun. 2026 was $8.65 Mil.
Endovia Health Sciences's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-13.75 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Endovia Health Sciences EV-to-EBIT Related Terms
Endovia Health Sciences EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Beverages - Wineries & Distilleries subindustry, Endovia Health Sciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Endovia Health Sciences EV-to-EBIT vs Beverages - Alcoholic Industry
For the Beverages - Alcoholic industry and Consumer Defensive sector, Endovia Health Sciences's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Endovia Health Sciences's EV-to-EBIT falls into.
Endovia Health Sciences's current Enterprise Value is $8.62 Mil.
Endovia Health Sciences's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-13.75 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Endovia Health Sciences (EDVA) has a EV-to-EBIT of -0.63 as of Aug. 25, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Endovia Health Sciences and its competitors. According to the industry distribution chart, Endovia Health Sciences ranks #999999 out of 161 companies in the Beverages - Alcoholic industry.
Is Endovia Health Sciences' EV-to-EBIT too high?
Endovia Health Sciences' current EV-to-EBIT is -0.63. Based on the distribution chart, Endovia Health Sciences ranks #999999 out of 161 companies in the Beverages - Alcoholic industry, which is in the bottom quartile relative to peers. Overall, Endovia Health Sciences has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Endovia Health Sciences' EV-to-EBIT compare to YHC and IBG?
According to the Beverages - Alcoholic industry distribution chart, Endovia Health Sciences ranks #999999 out of 161 companies for EV-to-EBIT. This places Endovia Health Sciences in the lower half of its industry. The industry median EV-to-EBIT is 13.96. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Beverages - Alcoholic company?
The median EV-to-EBIT among Beverages - Alcoholic companies is 13.96, based on 161 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Endovia Health Sciences and its competitors. For the Beverages - Alcoholic industry, the median EV-to-EBIT is 13.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Endovia Health Sciences's current EV-to-EBIT is -0.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Endovia Health Sciences stock overvalued right now?
Endovia Health Sciences (EDVA) has a current EV-to-EBIT of -0.63. The current EV-to-EBIT is -0.63. Endovia Health Sciences' overall GF Score™ is 20/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Endovia Health Sciences (EDVA), the current EV-to-EBIT is -0.63 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Splash Beverage Group Inc is a portfolio company managing multiple brands across several growth segments within the consumer beverage industry. The company's two reportable operating segments are: (1) the manufacture and distribution of non-alcoholic and alcoholic beverages, and (2) the retail sale of beverages and groceries online. The company generates the majority of its revenue from the E-Commerce.
20GF Score
Get the complete analysis for EDVA
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EDVA has been successfully added to your 
